A novel copper‐catalyzed cyclization provides efficient access to fluorinated quinoxalines from o ‐phenylenediamines and diazodicarbonyl compounds. Proceeding under mild conditions with broad substrate scope, this protocol delivers diverse derivatives in moderate to good yields, offering a streamlined approach to scaffolds valuable for medicinal and materials science applications.
Li et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: